Obesity is a major cause of morbidity and mortality worldwide. Tirzepatide is a glucose‐dependent insulinotropic polypeptide receptor and glucagon‐like peptide‐1 receptor agonist providing substantial weight reduction and metabolic benefits both… Click to show full abstract
Obesity is a major cause of morbidity and mortality worldwide. Tirzepatide is a glucose‐dependent insulinotropic polypeptide receptor and glucagon‐like peptide‐1 receptor agonist providing substantial weight reduction and metabolic benefits both in type 2 diabetes and obesity. We hypothesized that tirzepatide can improve morbidity and mortality in adults with obesity or overweight but without diabetes.
Keywords:
morbidity mortality;
morbidity;
mortality adults;
reduction;
adults obesity
Journal Title: Obesity
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Obesity
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!